Articles, App Notes, Case Studies, & White Papers

  1. A Proven Platform For Solid-Phase Oligonucleotide Synthesis 5/25/2022

    Facilitating oligonucleotide synthesis with state-of-the-art equipment and process support is critical to maximizing oligo production and achieving consistency at scale.

  2. Adapt Or Fail: The Urgency Of Pandemic Preparedness For Sterile Injectable Manufacturing 5/12/2025

    A successful large-scale public health emergency response requires adaptable manufacturing capabilities, an experienced workforce, and effective private-public partnerships.

  3. High-Throughput Lipid Separation For LNP Formulations 12/6/2024

    Lipid nanoparticles (LNPs) carry immense potential as delivery systems. Learn about the development of isocratic and gradient methods for high-throughput separation of lipids used in LNP formulations.

  4. 5 Key Considerations For Companies Outsourcing Process Development 6/9/2025

    Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

  5. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

  6. Expand Your Toolbox For Quality mRNA Manufacturing 4/9/2024

    Explore guidelines for the use of SP6 RNA Polymerase in mRNA synthesis and your mRNA production processes.

  7. Keeping The Momentum In Pandemic Preparedness 10/22/2024

    Learn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.

  8. PUPSIT As Part Of A Contamination Control Strategy (CCS) 8/21/2024

    Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.

  9. Key Insights Into Overcoming mRNA Process Challenges 9/8/2021

    Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.

  10. Tangential Flow Filtration System Coupling To Enhance Solution Offerings 3/1/2023

    Discover a simple, easy, and versatile method for capsule and depth filtration of small volumes that moves research from cell harvest to purification as quickly and efficiently as possible.